Literature DB >> 9529393

Hydroxychloroquine retinopathy: is screening necessary?

C Blyth, C Lane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529393      PMCID: PMC1112718          DOI: 10.1136/bmj.316.7133.716

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

Review 2.  Ocular safety of hydroxychloroquine.

Authors:  H N Bernstein
Journal:  Ann Ophthalmol       Date:  1991-08

3.  Screening for hydroxychloroquine retinal toxicity: is it necessary?

Authors:  C D Morsman; S J Livesey; I M Richards; J D Jessop; P V Mills
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

4.  Retinal toxicity in long term hydroxychloroquine treatment.

Authors:  M Mavrikakis; S Papazoglou; P P Sfikakis; G Vaiopoulos; K Rougas
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

5.  The sensitivity of Amsler grid testing in early chloroquine retinopathy.

Authors:  M Easterbrook
Journal:  Trans Ophthalmol Soc U K       Date:  1985

6.  Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials.

Authors:  A H Mackenzie
Journal:  Am J Med       Date:  1983-07-18       Impact factor: 4.965

7.  Hydroxychloroquine, dosage parameters and retinopathy.

Authors:  D J Spalton; G M Verdon Roe; G R Hughes
Journal:  Lupus       Date:  1993-12       Impact factor: 2.911

  7 in total
  3 in total

1.  Screening for hydroxychloroquine retinopathy. Screening should be selective.

Authors:  K May; T Metcalf; A Gough
Journal:  BMJ       Date:  1998-11-14

Review 2.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

3.  Ocular Side Effects of Systemic Drugs Used in Dermatology.

Authors:  Bhanu Prakash; H Mohan Kumar; Saranya Palaniswami; Borra Harish Lakshman
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.